Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huizhi Pharmaceutical is a China-based biotechnology company specializing in the discovery and development of innovative small molecule therapeutics. The company operates as an integrated platform, combining internal drug discovery programs with contract research and manufacturing services (CRO/CDMO) for the global pharmaceutical industry. Its primary therapeutic focus includes metabolic diseases, such as type 2 diabetes and obesity, as well as autoimmune and inflammatory conditions. Huizhi Pharmaceutical leverages its expertise in medicinal chemistry and process development to advance a pipeline of candidates through various stages of clinical development. The company is recognized for its high-quality API manufacturing and its commitment to providing cost-effective solutions for complex chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huizhi Pharmaceutical.